| Criterion Text | Inclusion/Exclusion | Disease | Biomarker | Prior Therapy | Criterion Rule |
| --- | --- | --- | --- | --- | --- |
| PSA < 20 | Inclusion | Prostate Cancer | PSA | None | PSA(<20) |

Note:

* PSA stands for Prostate Specific Antigen.
* The criterion text specifies an inclusion criterion for prostate cancer clinical trial, which states that the patient's PSA level must be less than 20.
* The disease associated with this criterion is Prostate Cancer.
* The biomarker associated with this criterion is PSA.
* There is no prior therapy specified in the given criterion text.
* The criterion rule is represented as PSA(<20), which means the patient's PSA level must be less than 20 to meet the inclusion criterion.